Stock BLO CANNABIX TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cannabix Technologies Inc.

Equities

BLO

CA13765L1013

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange
Other stock markets
 03:53:51 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.465 CAD 0.00% Intraday chart for Cannabix Technologies Inc. +86.00% +158.33%
Apr. 25 Cannabix Up 28% as it Says Breath Logix Alcohol Device Delivers "Positive Impact" to Private Monitoring Agency in Montana MT
Apr. 16 Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands Product Series to Breath Logix CI

Valuation

Fiscal Period: April 2018 2019 2020 2021 2022 2023
Capitalization 1 180.5 122.7 41 150.6 61.64 35.96
Enterprise Value (EV) 1 169.5 112.5 32.56 140.5 53.18 29.62
P/E ratio -114 x -31 x -5.85 x -15.5 x -18.3 x -16.8 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -126 x -29.3 x -4.73 x -15.4 x -17.1 x -14.7 x
EV / FCF -192 x -273 x 43 x -29 x -72.8 x -23.6 x
FCF Yield -0.52% -0.37% 2.33% -3.45% -1.37% -4.23%
Price to Book 12.5 x 8.56 x 4.74 x 14.6 x 7.13 x 5.36 x
Nbr of stocks (in thousands) 97,576 104,024 105,124 112,379 114,144 114,144
Reference price 2 1.850 1.180 0.3900 1.340 0.5400 0.3150
Announcement Date 8/28/18 8/22/19 8/28/20 8/27/21 8/17/22 8/25/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: April 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -1.342 -3.835 -6.888 -9.108 -3.115 -2.011
EBIT 1 -1.359 -3.855 -6.91 -9.134 -3.144 -2.137
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -1.468 -3.88 -6.971 -9.243 -3.368 -2.138
Net income 1 -1.468 -3.88 -6.971 -9.243 -3.368 -2.138
Net margin - - - - - -
EPS 2 -0.0162 -0.0381 -0.0666 -0.0863 -0.0295 -0.0187
Free Cash Flow 1 -0.8827 -0.4127 0.7579 -4.851 -0.7308 -1.252
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/28/18 8/22/19 8/28/20 8/27/21 8/17/22 8/25/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: April 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 11 10.3 8.44 10.1 8.45 6.34
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.88 -0.41 0.76 -4.85 -0.73 -1.25
ROE (net income / shareholders' equity) -13.1% -26.5% -60.6% -97.6% -35.6% -27.9%
ROA (Net income/ Total Assets) -7.49% -16.2% -37.1% -59.7% -20.5% -17%
Assets 1 19.61 23.88 18.8 15.48 16.4 12.57
Book Value Per Share 2 0.1500 0.1400 0.0800 0.0900 0.0800 0.0600
Cash Flow per Share 2 0.1100 0.1000 0.0800 0.0900 0.0700 0.0600
Capex 1 0.12 0.06 - 0.08 0 0.03
Capex / Sales - - - - - -
Announcement Date 8/28/18 8/22/19 8/28/20 8/27/21 8/17/22 8/25/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
CANNABIX TECHNOLOGIES INC. Stock Cannabix Technologies Inc.
+158.33% 38.77M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. BLO Stock
  4. Financials Cannabix Technologies Inc.